💨 Abstract

ProQR Therapeutics (PRQR) reported a second-quarter loss of $13.8 million, or 14 cents per share, missing Wall Street's expectations of an 8 cent per share loss. The company, based in Leiden, Netherlands, recorded $4.3 million in revenue during the quarter.

Courtesy: WTOP Staff